Atlas Trials

A Study of a Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive Disorder

Clinical trial NCT05385783 · COMPLETED

Trial details

NCT number
NCT05385783
Sponsor
Cybin IRL Limited
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2022-08-02
Primary completion
2023-10-16
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.